Hib-DTP vaccine (Cadila Healthcare)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHib-DTP vaccine (Cadila Healthcare)
Drug Alias NameDiphtheria-tetanus-haemophilus infections-whole cell pertussis vaccine
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaHaemophilus Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesZydus Lifesciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZydus Lifesciences Ltd
Inactive CompaniesN/A
Active IndicationsTetanusDiphtheriaHaemophilus Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A